Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus SSRIs versus valproate for medium- and long-term efficacy in alcohol dependence
ChiCTR2000036214Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xinxiang Medical University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin and valproic acid in alcohol dependence (3 arms), sponsored by The Second Affiliated Hospital of Xinxiang Medical University. Primary endpoints: Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised, Penn Alcohol Craving Scale and 10 more. Started Sep 2020; status: recruiting.
02
Drugs
gabapentinvalproic acid
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on ChiCTR2000036214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036214.